首页>
外国专利>
A novel polypeptide-homo negative regulator 21 of programmed cell death and polynucleotide encoding said polypeptide
A novel polypeptide-homo negative regulator 21 of programmed cell death and polynucleotide encoding said polypeptide
展开▼
机译:程序性细胞死亡的新型多肽-同源负调节剂21和编码所述多肽的多核苷酸
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention discloses a new kind of polypeptide-HOMO negative regulator 21 of programmed cell death and polynucleotide encoding said polypeptide and a process for producing said polypeptide by DNA recombinant methods. It also discloses the method of applying the polypeptide for the treatment of various kinds of diseases, such as cancer, disorder of embryonic growth, immune disease, eccyliosis, phlogosis, hemopathy, and HIV infection. antagonist and the therapeutic use of the polypeptide is also disclosed. In addition, it refers to the use of polynucleotide encoding said HOMO negative regulator 21 of programmed cell death.
展开▼